Kevin M Hellman is an expert in Gynecology at University of Chicago (United States). As of October 2026, ScienceLeadR ranks Kevin M Hellman in the top 1% of experts worldwide for Dysmenorrhea and Pain. Kevin M Hellman has authored 74 publications, the most recent in 2026, and is an investigator in 3 clinical trials, 1 of them ongoing. SLR score: 318 (community average: 125). How the SLR is computed.

LeadR Profile

Kevin M Hellman University of Chicago United States
318 ScienceLeadR Reputation 318
Network Map

Gynecology

Subspecialties: Obstetrics - Neurology - Psychology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2007 - 2026

Source: PubMed

University of Chicago

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 74

Citations

Citations: 1 062 1st author: 14 Last author: 33 Unique author: 0


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Multimodal hypersensitivity across the menarcheal transition is associated with pelvic pain in adolescents: a longitudinal study.
PMID 42818905 — urinary bladder, longitudinal studies, pain, hypersensitivity, adolescent, dysmenorrhea, pelvic pain
medRxiv20260
\Stopping Dysmenorrhea: A Systematic Review of Drugs Inhibiting Uterine Contractions.
PMID 42746335 — bias, pain, pharmaceutical preparations, uterine contraction, dysmenorrhea, therapeutics
J Endometr Uterine Disord20260
Somatic Symptoms Before Menarche: The Role of Parents and Pain Sensitivity.
PMID 42602744 — depression, medically unexplained symptoms, menarche, pain, stress, physiological, signs and symptoms, adolescent, psychological distress
J Early Adolesc20260
Exploring predictors of analgesic response in adult women regularly using NSAIDs: insights from a machine learning approach.
PMID 42591126 — pain, sleep, anti-inflammatory agents, non-steroidal, machine learning, signs and symptoms, dysmenorrhea, analgesics, learning, non-responder
Front Pain Res (Lausanne)20260
Expression of circulating GRP78 and gp96, endoplasmic reticulum stress-related proteins, in menstrual and bladder pain sensitivity.
PMID 42373684 — urinary bladder, naproxen, pain, stress, physiological, endoplasmic reticulum stress, contraceptives, oral, dysmenorrhea, endoplasmic reticulum, natural science disciplines, contraceptive agents
Sci Rep20260

Clinical Studies 3

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

Phase 4 3

By status:

Completed 2
Recruiting 1

By type:

Interventional 3

By Monocentric/Multicentric:

monocentric 3
multicentric2to4 0
multicentric5to9 0
multicentricup10 0

Main Topics

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
NSAID Use for Treating Dysmenorrhea and Preventing Chronic Pelvic Pain (NSAID HEAL)
NCT06861920 — naproxen, blood, pain, pharmaceutical preparations, multiple chronic conditions, tablets, anti-inflammatory agents, non-steroidal, acetaminophen, signs and symptoms, dysmenorrhea, research, pelvic pain, therapeutics, absorption
Phase 4Recruiting2025

LeadR Networks

Main global connection map